101 related articles for article (PubMed ID: 11734204)
1. Overproduced p73alpha activates a minimal promoter through a mechanism independent of its transcriptional activity.
Takagi S; Ueda Y; Hijikata M; Shimotohno K
FEBS Lett; 2001 Nov; 509(1):47-52. PubMed ID: 11734204
[TBL] [Abstract][Full Text] [Related]
2. p73 independent of c-Myc represses transcription of platelet-derived growth factor beta-receptor through interaction with NF-Y.
Hackzell A; Uramoto H; Izumi H; Kohno K; Funa K
J Biol Chem; 2002 Oct; 277(42):39769-76. PubMed ID: 12167641
[TBL] [Abstract][Full Text] [Related]
3. HMGB1 and HMGB2 cell-specifically down-regulate the p53- and p73-dependent sequence-specific transactivation from the human Bax gene promoter.
Stros M; Ozaki T; Bacikova A; Kageyama H; Nakagawara A
J Biol Chem; 2002 Mar; 277(9):7157-64. PubMed ID: 11748232
[TBL] [Abstract][Full Text] [Related]
4. p73 function is inhibited by tumor-derived p53 mutants in mammalian cells.
Di Como CJ; Gaiddon C; Prives C
Mol Cell Biol; 1999 Feb; 19(2):1438-49. PubMed ID: 9891077
[TBL] [Abstract][Full Text] [Related]
5. Deletion of the COOH-terminal region of p73alpha enhances both its transactivation function and DNA-binding activity but inhibits induction of apoptosis in mammalian cells.
Ozaki T; Naka M; Takada N; Tada M; Sakiyama S; Nakagawara A
Cancer Res; 1999 Dec; 59(23):5902-7. PubMed ID: 10606232
[TBL] [Abstract][Full Text] [Related]
6. New p73 variants with altered C-terminal structures have varied transcriptional activities.
Ueda Y; Hijikata M; Takagi S; Chiba T; Shimotohno K
Oncogene; 1999 Sep; 18(35):4993-8. PubMed ID: 10490834
[TBL] [Abstract][Full Text] [Related]
7. p73 transcriptional activity increases upon cooperation between its spliced forms.
Alarcon-Vargas D; Fuchs SY; Deb S; Ronai Z
Oncogene; 2000 Feb; 19(6):831-5. PubMed ID: 10698502
[TBL] [Abstract][Full Text] [Related]
8. Relief of p53-mediated telomerase suppression by p73.
Toh WH; Kyo S; Sabapathy K
J Biol Chem; 2005 Apr; 280(17):17329-38. PubMed ID: 15734740
[TBL] [Abstract][Full Text] [Related]
9. Two new p73 splice variants, gamma and delta, with different transcriptional activity.
De Laurenzi V; Costanzo A; Barcaroli D; Terrinoni A; Falco M; Annicchiarico-Petruzzelli M; Levrero M; Melino G
J Exp Med; 1998 Nov; 188(9):1763-8. PubMed ID: 9802988
[TBL] [Abstract][Full Text] [Related]
10. Identification of protein kinase A catalytic subunit beta as a novel binding partner of p73 and regulation of p73 function.
Hanamoto T; Ozaki T; Furuya K; Hosoda M; Hayashi S; Nakanishi M; Yamamoto H; Kikuchi H; Todo S; Nakagawara A
J Biol Chem; 2005 Apr; 280(17):16665-75. PubMed ID: 15723830
[TBL] [Abstract][Full Text] [Related]
11. p73beta inhibits transcriptional activities of enhancer I and X promoter in hepatitis B virus more efficiently than p73alpha.
Xu ZH; Zhao MJ; Li TP
World J Gastroenterol; 2002 Dec; 8(6):1094-7. PubMed ID: 12439932
[TBL] [Abstract][Full Text] [Related]
12. Full-length p73alpha represses drug-induced apoptosis in small cell lung carcinoma cells.
Nyman U; Sobczak-Pluta A; Vlachos P; Perlmann T; Zhivotovsky B; Joseph B
J Biol Chem; 2005 Oct; 280(40):34159-69. PubMed ID: 16087678
[TBL] [Abstract][Full Text] [Related]
13. p73alpha expression induces both accumulation and activation of wt-p53 independent of the p73alpha transcriptional activity.
Miro-Mur F; Meiller A; Haddada H; May E
Oncogene; 2003 Aug; 22(35):5451-6. PubMed ID: 12934105
[TBL] [Abstract][Full Text] [Related]
14. p73 competes with co-activators and recruits histone deacetylase to NF-Y in the repression of PDGF beta-receptor.
Uramoto H; Wetterskog D; Hackzell A; Matsumoto Y; Funa K
J Cell Sci; 2004 Oct; 117(Pt 22):5323-31. PubMed ID: 15454570
[TBL] [Abstract][Full Text] [Related]
15. Function of p73, not of p53, is inhibited by the physical interaction with RACK1 and its inhibitory effect is counteracted by pRB.
Ozaki T; Watanabe K; Nakagawa T; Miyazaki K; Takahashi M; Nakagawara A
Oncogene; 2003 May; 22(21):3231-42. PubMed ID: 12761493
[TBL] [Abstract][Full Text] [Related]
16. Role of p73 in regulating human caspase-1 gene transcription induced by interferon-{gamma} and cisplatin.
Jain N; Gupta S; Sudhakar Ch; Radha V; Swarup G
J Biol Chem; 2005 Nov; 280(44):36664-73. PubMed ID: 16135520
[TBL] [Abstract][Full Text] [Related]
17. Promoter specificity and stability control of the p53-related protein p73.
Lee CW; La Thangue NB
Oncogene; 1999 Jul; 18(29):4171-81. PubMed ID: 10435630
[TBL] [Abstract][Full Text] [Related]
18. Kinase activity-independent suppression of p73alpha by AMP-activated kinase alpha (AMPKalpha).
Lee YG; Lee SW; Sin HS; Kim EJ; Um SJ
Oncogene; 2009 Feb; 28(7):1040-52. PubMed ID: 19079340
[TBL] [Abstract][Full Text] [Related]
19. Functional characterization of naturally occurring mutants (P405R and P425L) of p73alpha and p73beta found in neuroblastoma and lung cancer.
Naka M; Ozaki T; Takada N; Takahashi M; Shishikura T; Sakiyama S; Tada M; Todo S; Nakagawara A
Oncogene; 2001 Jun; 20(27):3568-72. PubMed ID: 11429704
[TBL] [Abstract][Full Text] [Related]
20. Ectopic expression of p73alpha, but not p73beta, suppresses myogenic differentiation.
Li CY; Zhu J; Wang JY
J Biol Chem; 2005 Jan; 280(3):2159-64. PubMed ID: 15545283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
